Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer

Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer

<b>Background:</b> Adherence to oral anticancer therapies among breast cancer patients is an often-overlooked issue. A lack of patient compliance can be caused by several factors, and may hinder the efficacy of prescribed medication, leading to a shorter than expected survival. In this c...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Rosaria Valerio, Federica Martorana, Maria Vita Sanò, Daniela Sambataro, Gianmarco Motta, Lucia Motta, Giuliana Pavone, Vittorio Gebbia, Giuseppa Scandurra
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Biomedicines
Subjects:
abemaciclib
breast cancer
adherence
barriers
dose-intensity
drug claims
Online Access:https://www.mdpi.com/2227-9059/13/3/546
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/13/3/546

Similar Items